Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Morgan

Showing results (111-120 of 177) with videos related to

Pageof 18
Sort By:
Hepatology Communications|July 5, 2024
Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction-associated steatotic liver diseaseDavid E Kaplan, Craig C Teerlink, Tae-Hwi Schwantes-An, et al.
The American Journal of Pathology|June 19, 2026
Unbiased Spatial Proteomics Uncovers Hepatic In Situ Regulation in Alcohol-Associated HepatitisLe Z Day, Maria Hernandez-Tejero, Nidhi Jalan Sakrikar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFPTimothy R Morgan, Kathryn Osann, Teodoro Bottiglieri, et al.
Gastroenterology|March 10, 2010
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.
Gastroenterology|February 28, 2016
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis ConsortiaDavid W Crabb, Ramon Bataller, Naga P Chalasani, et al.
BMC Health Services Research|January 28, 2025
Screening high-risk Veterans for cirrhosis: taking a stepwise population health approachJonathan Dounel, Carolyn Lamorte, Heather Patton, et al.
Hepatology (Baltimore, Md.)|December 30, 2025
Erratum: Pilot trials of oral betaine in participants with non-alcoholic fatty liver disease and elevated alanine aminotransferaseAndrew S Lim, Sheena N Cruz, Aliya Asghar Uddin, et al.
Journal of Hepatology|January 2, 2007
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosisHerbert L Bonkovsky, Kristin K Snow, Peter F Malet, et al.
Hepatology (Baltimore, Md.)|April 1, 2024
Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty DelphiElliot B Tapper, Matthew A Warner, Rajesh P Shah, et al.
Cellular Immunology|July 21, 2009
Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factorLisheng Ge, Jian Gang Zhang, Christina A Samathanam, et al.
Pageof 18

Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
Hepatology Communications|July 5, 2024
Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction-associated steatotic liver diseaseDavid E Kaplan, Craig C Teerlink, Tae-Hwi Schwantes-An, et al.
The American Journal of Pathology|June 19, 2026
Unbiased Spatial Proteomics Uncovers Hepatic In Situ Regulation in Alcohol-Associated HepatitisLe Z Day, Maria Hernandez-Tejero, Nidhi Jalan Sakrikar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFPTimothy R Morgan, Kathryn Osann, Teodoro Bottiglieri, et al.
Gastroenterology|March 10, 2010
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.
Gastroenterology|February 28, 2016
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis ConsortiaDavid W Crabb, Ramon Bataller, Naga P Chalasani, et al.
BMC Health Services Research|January 28, 2025
Screening high-risk Veterans for cirrhosis: taking a stepwise population health approachJonathan Dounel, Carolyn Lamorte, Heather Patton, et al.
Hepatology (Baltimore, Md.)|December 30, 2025
Erratum: Pilot trials of oral betaine in participants with non-alcoholic fatty liver disease and elevated alanine aminotransferaseAndrew S Lim, Sheena N Cruz, Aliya Asghar Uddin, et al.
Journal of Hepatology|January 2, 2007
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosisHerbert L Bonkovsky, Kristin K Snow, Peter F Malet, et al.
Hepatology (Baltimore, Md.)|April 1, 2024
Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty DelphiElliot B Tapper, Matthew A Warner, Rajesh P Shah, et al.
Cellular Immunology|July 21, 2009
Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factorLisheng Ge, Jian Gang Zhang, Christina A Samathanam, et al.
Pageof 18